multiple myeloma

Showing 1 - 25 of 1,605

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

Recruiting
  • Multiple Myeloma
  • Autologous hematopoietic stem cell transplantation
  • C-CAR088
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 21, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Nov 29, 2022

Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CAR-T Autologous T cell injection
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Nov 23, 2022

Carfilzomib in Patients With Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
Nov 17, 2022

Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell Trial in Cangzhou (CAR-T)

Recruiting
  • Lymphoma, B-Cell
  • +3 more
  • CAR-T
  • Cangzhou, Hebei, China
    Cangzhou People's Hospital
Nov 9, 2022

Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA Targeted T Cells Injection
  • Shanghai, Shanghai, China
  • +1 more
Oct 21, 2022

Multiple Myeloma Trial (Modakafusp Alfa, Daratumumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 19, 2022

Breast Cancer, Lung Cancer, Gastrointestinal Cancer Trial in Cleveland (survey)

Recruiting
  • Breast Cancer
  • +3 more
  • survey
  • Cleveland, Ohio
    Cleveland Clinic
Oct 18, 2022

Multiple Myeloma Trial (Cevostamab, Lenalidomide, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 14, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Ultra-low-dose Whole-body CT Using AI-based CT Reconstruction in

Not yet recruiting
  • Multiple Myeloma
  • noncontrast-enhanced whole-body CT
  • (no location specified)
Oct 10, 2022

Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +7 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 11, 2022

ctDNA Methylation Sequencing for Myeloma

Recruiting
  • Multiple Myeloma
  • plasma circulation DNA methylation sequencing
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Oct 11, 2022

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 6, 2022

Ovarian Cancer, AIDS-related Kaposi Sarcoma, Multiple Myeloma Trial (DOXIL/CAELYX)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • (no location specified)
Sep 30, 2022

Learn About Medicine in People With Relapsed Refractory Multiple

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

Not yet recruiting
  • Cancer Prevention
  • +5 more
  • Prolonged Fasting Intervention
  • EDUCATION CONTROL
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 3, 2022

Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)

Not yet recruiting
  • Multiple Myeloma
  • Modakafusp alfa
  • +5 more
  • Little Rock, Arkansas
  • +38 more
Sep 29, 2022

Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine
Sep 26, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • Pomalidomide 4 mg every day in cycle 1
  • +4 more
  • (no location specified)
Sep 26, 2022

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • La Jolla, California
  • +165 more
Sep 27, 2022

Multiple Myeloma Trial in United States (Belantamab Mafodotin, Nirogacestat)

Not yet recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 22, 2022

Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia Trial in Birmingham

Recruiting
  • Multiple Myeloma
  • +2 more
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Sep 22, 2022

    HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (BNT162b2, mRNA-1273, NVX-COV2373)

    Not yet recruiting
    • HIV
    • +5 more
    • BNT162b2
    • +2 more
    • Melbourne, Victoria, Australia
      Alfred Health
    Sep 25, 2022